Abstract
OBJECTIVES: Both clinical trials and observational studies of persons with HIV infection commonly include health-related quality of life (HRQOL) measures, but less is known about the relation of HRQOL to survival among persons with HIV since the development of effective antiretroviral treatment.
DESIGN/PARTICIPANTS: Prospective cohort study of a national probability sample of 2,864 adults receiving HIV care.
INDEPENDENT VARIABLES: The main independent variables were derived from the HIV Cost and Services Utilization Study (HCSUS) HRQOL measure, and include physical and mental HRQOL summary scores (divided into quartiles) constructed from the following items administered at baseline: physical functioning (9 items, α=0.91), role functioning (2 items, α=0.85), pain (2 items, α=0.84), general health perceptions (3 items, α=0.80), emotional well-being (7 items, α=0.90), social functioning (2 items, α=0.82), energy (2 items, α=0.74), and a single-item measure of disability days (days in bed for at least 0.5 day due to health).
MAIN OUTCOME VARIABLE: Death between January 1996 and December 1999.
ANALYSIS: Descriptive and multivariate adjusted Cox proportional hazards regression analysis of survival by physical and mental HRQOL.
RESULTS: By December 1999, 17% of the sample had died. In unadjusted analysis, persons in the higher quartiles of physical HRQOL, as well as those in the higher quartiles of mental HRQOL at baseline, had significantly better survival than those in lower quartiles. In multiple regressions controlling for a number of sociodemographic and clinical variables, the hazard of death for those in the highest quartile of physical HRQOL was one quarter of that for those in the lowest quartile. This difference was similar in magnitude to that observed for being on highly active antiretroviral therapy versus no antiretrovirals in this population. By contrast, there was no unique association of mental HRQOL with survival.
CONCLUSIONS: Physical HRQOL added prognostic information over and above the sociodemographic and routinely available clinical data such as CD4 count and stage of HIV infection. Measurement of HRQOL, which is often performed to identify problems or assess outcomes, is also useful prognostically.
Similar content being viewed by others
References
Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, December 2001 Year-end Edition. Atlanta, GA: Centers for Disease Control and Prevention; 2001;13:1–48.
Hays RD, Cunningham WE, Sherbourne CD, et al. Health-related quality of life in patients with Human Immunodeficiency Virus Infection in the United States: results from the HIV Cost and Services Utilization Study. Am J Med. 2000;108:714–22.
Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life: a conceptual model of patient outcomes. JAMA. 1995;273:59–65.
Ganz PA, Schag CAC, Kahn B, Petersen L. Assessing the quality of life of HIV infected persons: clinical and descriptive information from studies with The Hopes. Psychol Health. 1994;9:93–110.
Globe DR, Hays RD, Cunningham WE. Associations of clinical parameters with health-related quality of life in hospitalized persons with HIV disease. AIDS Care. 1999;11:71–86.
Wu A, Hays RD, Kelly S, Malitz KF, Bozzette SA. Applications of the medical outcomes study health-related quality of life measures in HIV/AIDS. Qual Life Res. 1997;6:531–54.
Bozzette SA, Hays RD, Berry SH, Kanouse DE, Wu AW. Derivation and properties of a brief health status assessment instrument for use in HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8:253–65.
Chan KS, Revicki DA. Changes in surrogate laboratory markers, clinical endpoints, and health-related quality of life in patients infected with the human immunodeficiency virus. Eval Health Prof. 1998;21:265–81.
Brechtl JR, Breitbart W, Galietta M, Krivo S, Rosenfeld B. The use of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection: impact on medical, palliative care, and quality of life outcomes. J Pain Symptom Manage. 2001;21:41–51.
Starace F, Ammassari A, Trotta MP, et al. Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;31(suppl 3):S136-S139.
Palella FJ, Delaney KM, Moorman A, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853–60.
Frankel MR, Shapiro MF, Duan N, et al. National probability samples in studies of low-prevalence diseases, part 2: designing and implementing the HIV cost and services utilization study sample. Health Serv Res. 1999;34:969–92.
Hays RD, Spritzer KL, McCaffrey DF, et al. The HIV Cost and Services Utilization Study (HCSUS) Measures of Health-related Quality of Life. Santa Monica, CA: RAND; 1998:DRU-1897-AHCPR.
Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Department of Health and Human Services and Henry J. Kaiser Family Foundation. MMWR Recomm Rep. 1998;47(RR-5):43–82.
Cunningham WE, Markson LE, Andersen RM, et al. Prevalence and predictors of highly active antiretroviral therapy use in persons with HIV infection in the U.S. J Acquir Immune Defic Syndr. 2000;25:115–23.
Stata Corporation. Stata Reference Manual, V7.0. College Station, TX: Stata Corporation; 2000.
Bozzette SA, Berry SH, Duan N, et al. The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium. N Engl J Med. 1998;339:1897–904.
Fleishman JA, Crystal S. Functional status transition and survival in HIV disease: evidence from the AIDS Costs and Service Utilization Survey. Med Care. 1998;36:533–43.
Jacobson DL, Wu AW, Feinberg J. Outcomes Committee of the Adult AIDS Clinical Trials Group. Health-related quality of life predicts survival, cytomegalovirus disease, and study retention in clinical trial participants with advanced HIV disease. J Clin Epidemiol. 2003;56:874–9.
Inouye SK, Peduzzi PN, Robison JT, Hughes JS, Horwitz RI, Concato J. Importance of functional measures in predicting mortality among older hospitalized patients. JAMA. 1998;279:1187–93.
Rumsfeld JS, MaWhinney S, McCarthy M, et al. Health-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. Participants of the Department of Veterans Affairs Cooperative Study Group on Processes, Structures, and Outcomes of Care in Cardiac Surgery. JAMA. 1999;281:1298–303.
Lee Y. The predictive value of self assessed general, physical, and mental health on functional decline and mortality in older adults. J Epidemiol Community Health. 2000;54:123–9.
Idler EL, Kasl S. Health perceptions and survival: do global evaluations of health status really predict mortality? J Gerontol. 1991;46:S55-S65.
Ware J, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User’s Manual. Boston, MA: The Health Institute, New England Medical Center; 1994.
Konstam V, Salem D, Pouleur H, et al. Baseline quality of life as a predictor of mortality and hospitalization in 5,025 patients with congestive heart failure. SOLVD Investigations. Studies of Left Ventricular Dysfunction Investigators. Am J Cardiol. 1996;78:890–5.
Reuben DB, Rubenstein LV, Hirsch SH, Hays RD. Value of functional status as a predictor of mortality: results of a prospective study. Am J Med. 1992;93:663–9.
Idler EL, Benyamini Y. Self-rated health and mortality: a review of twenty-seven community studies. J Health Soc Behav. 1997;38:21–37.
Douaihy A, Singh N. Factors affecting quality of life in patients with HIV infection. AIDS Read. 2001;11:450–4; 460–1, 475.
O’Leary JF, Ganz PA, Wu AW, Coscarelli A, Petersen L. Toward a better understanding of health-related quality of life: a comparison of the Medical Outcomes Study HIV Health Survey (MOS-HIV) and the HIV Overview of Problems-Evaluation System (HOPES). J Acquir Immune Defic Syndr Hum Retrovirol. 1998;17:433–41.
Wilson IB, Cleary PD. Clinical predictors of declines in physical functioning in persons with AIDS: results of a longitudinal study. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;16:343–9.
Cunningham WE, Hays RD, Ettl MK, et al. The prospective effect of access to medical care on health-related quality-of-life outcomes in patients with symptomatic HIV disease. Med Care. 1998;36:295–306.
Reemtsma K, Morgan M. Outcomes assessment: a primer. Bull Am Coll Surg. 1997;82:34–9.
Detmar SB, Muller MJ, Schornagel JH, Wever LD, Aaronson NK. Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. JAMA. 2002;288:3027–34.
Kiebzak GM, Campbell M, Mauerhan DR. The SF-36 general health status survey documents the burden of osteoarthritis and the benefits of total joint arthroplasty: but why should we use it? Am J Manag Care. 2002;8:463–74.
Gilbody SM, House AO, Sheldon T. Routine administration of Health Related Quality of Life (HRQoL) and needs assessment instruments to improve psychological outcome—a systematic review. Psychol Med. 2002;32:1345–56.
Hays RD, Stewart AL. The structure of self-reported health in chronic disease patients. Psychol Assess. 1990;2:22–30.
Hays RD, Prince-Embury S, Chen H. R-36 HSI: RAND-36 Health Status Inventory. San Antonio, TX: The Psychological Corporation; 1998.
Ware JE Jr, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care. 1995;33:AS264-AS279.
de Boer AG, Wijker W, Speelman JD, de Haes JC. Quality of life in patients with Parkinson’s disease: development of a questionnaire. J Neurol Neurosurg Psychiatry. 1996;61:70–4.
Author information
Authors and Affiliations
Corresponding author
Additional information
The HIV Cost and Services Utilization Study was conducted under cooperative agreement U-01 HS08578 (M.F. Shapiro, Pl; S.A. Bozzette, Co-Pl) between RAND and the Agency for Health Research and Quality. Substantial additional funding for this cooperative agreement was provided by the Health Resources and Services Administration, the National Institute of Mental Health, the National Institute on Drug Abuse, and the National Institutes of Health Office of Research on Minority Health through the National Institute of Dental Research. Additional support was provided by Merck and Company Incorporated, Glaxo-Wellcome Incorporated, the National Institute on Aging, and the Office of the Assistant Secretary for Planning and Evaluation in the U.S. Department of Health and Human Services. Dr. Hays was supported by a grant from the National Institute of Health (Al 28697). Drs. Cunningham and Hays also received partial support from the UCLA-Drew Project Export, National Institutes of Health, National Center on Minority Health and Health Disparities, (P20-MD00148-01), and the UCLA Center for Health Improvement in Minority Elders/Resource Centers for Minority Aging Research, National Institutes of Health, National Institute of Aging (AG-02-004).
Rights and permissions
About this article
Cite this article
Cunningham, W.E., Crystal, S., Bozzette, S. et al. The association of health-related quality of life with survival among persons with HIV infection in the united states. J GEN INTERN MED 20, 21–27 (2005). https://doi.org/10.1111/j.1525-1497.2005.30402.x
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1525-1497.2005.30402.x